Sanofi India Ltd — Board/Management Information 2021

Aug 13, 2021

==> picture [89 x 70] intentionally omitted <==

13[th] August 2021

The Secretary The Secretary Bombay Stock Exchange Limited The National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, 5[th] Floor Dalal Street Plot No. C/1, G Block Mumbai 400 001 Bandra-Kurla Complex, Bandra East Mumbai 400 050 --------------------------------------------------------------------------------------------------------------------------

Resignation of Company Secretary (Key Managerial Personnel) & Change in Compliance Officer

Dear Sirs,

As required under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that Mr. Girish Tekchandani has resigned from the position of Company Secretary (Key Managerial Personnel) and Compliance Officer of the Company to pursue other opportunities outside of Sanofi. The resignation has been accepted and he will be relieved from his responsibilities at the end of business hours on 31[st] August 2021.

The successor of Mr. Girish Tekchandani will be announced separately.

Pursuant to Regulation 6 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Mr. Vaibhav Karandikar, Whole Time Director and Chief Financial Officer (ACS No. 13110) will be the Compliance Officer of the Company with effect from 1[st] September 2021, till further announcement on this matter.

Request you to take above information on record.

Thanking you,

Yours faithfully

For SANOFI INDIA LIMITED

==> picture [110 x 63] intentionally omitted <==

RAJARAM NARAYANAN MANAGING DIRECTOR

==> picture [544 x 16] intentionally omitted <==